Trials / Not Yet Recruiting
Not Yet RecruitingNCT06981845
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis (STOP-RECUR) Study
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (estimated)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate, through a multicenter, prospective, double-blind, randomized, placebo-controlled clinical trial, whether immunosuppressive therapy improves target lesion-related cardiovascular outcomes compared to placebo treatment in patients with Rapid rEcurrence of Coronary Unexplained in-stent Restenosis (RECUR).
Conditions
- In-stent Restenosis Lesion
- Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Immunosuppressive therapy | prednisone + sirolimus |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2028-06-01
- Completion
- 2028-06-01
- First posted
- 2025-05-21
- Last updated
- 2025-05-21
Source: ClinicalTrials.gov record NCT06981845. Inclusion in this directory is not an endorsement.